153 related articles for article (PubMed ID: 38552851)
21. PARkinson's: From cellular mechanisms to potential therapeutics.
Lengyel-Zhand Z; Puentes LN; Mach RH
Pharmacol Ther; 2022 Feb; 230():107968. PubMed ID: 34391789
[TBL] [Abstract][Full Text] [Related]
22. The dual role of poly(ADP-ribose) polymerase-1 in modulating parthanatos and autophagy under oxidative stress in rat cochlear marginal cells of the stria vascularis.
Jiang HY; Yang Y; Zhang YY; Xie Z; Zhao XY; Sun Y; Kong WJ
Redox Biol; 2018 Apr; 14():361-370. PubMed ID: 29049980
[TBL] [Abstract][Full Text] [Related]
23. LPS protects macrophages from AIF-independent parthanatos by downregulation of PARP1 expression, induction of SOD2 expression, and a metabolic shift to aerobic glycolysis.
Regdon Z; Robaszkiewicz A; Kovács K; Rygielska Ż; Hegedűs C; Bodoor K; Szabó É; Virág L
Free Radic Biol Med; 2019 Feb; 131():184-196. PubMed ID: 30502458
[TBL] [Abstract][Full Text] [Related]
24. PARP1 inhibition alleviates injury in ARH3-deficient mice and human cells.
Mashimo M; Bu X; Aoyama K; Kato J; Ishiwata-Endo H; Stevens LA; Kasamatsu A; Wolfe LA; Toro C; Adams D; Markello T; Gahl WA; Moss J
JCI Insight; 2019 Feb; 4(4):. PubMed ID: 30830864
[TBL] [Abstract][Full Text] [Related]
25. Observation of Parthanatos Involvement in Diminished Ovarian Reserve Patients and Melatonin's Protective Function Through Inhibiting ADP-Ribose (PAR) Expression and Preventing AIF Translocation into the Nucleus.
Batnasan E; Xie S; Zhang Q; Li Y
Reprod Sci; 2020 Jan; 27(1):75-86. PubMed ID: 32046374
[TBL] [Abstract][Full Text] [Related]
26. PAAN/MIF nuclease inhibition prevents neurodegeneration in Parkinson's disease.
Park H; Kam TI; Peng H; Chou SC; Mehrabani-Tabari AA; Song JJ; Yin X; Karuppagounder SS; Umanah GK; Rao AVS; Choi Y; Aggarwal A; Chang S; Kim H; Byun J; Liu JO; Dawson TM; Dawson VL
Cell; 2022 May; 185(11):1943-1959.e21. PubMed ID: 35545089
[TBL] [Abstract][Full Text] [Related]
27. Knockdown of macrophage migration inhibitory factor (MIF), a novel target to protect neurons from parthanatos induced by simulated post-spinal cord injury oxidative stress.
Yang D; Shu T; Zhao H; Sun Y; Xu W; Tu G
Biochem Biophys Res Commun; 2020 Mar; 523(3):719-725. PubMed ID: 31948762
[TBL] [Abstract][Full Text] [Related]
28. PARP-1 dependent cell death pathway (Parthanatos) mediates early brain injury after subarachnoid hemorrhage.
Han Y; Wang C; Li X; Liang G
Eur J Pharmacol; 2024 Jun; 978():176765. PubMed ID: 38906236
[TBL] [Abstract][Full Text] [Related]
29. Iduna protects HT22 cells by inhibiting parthanatos: The role of the p53-MDM2 pathway.
Xu H; Li X; Wu X; Yang Y; Dai S; Lei T; Jing D; Luo P; Luo E
Exp Cell Res; 2019 Nov; 384(1):111547. PubMed ID: 31472117
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of AKT induces p53/SIRT6/PARP1-dependent parthanatos to suppress tumor growth.
Zhang Y; Zhang C; Li J; Jiang M; Guo S; Yang G; Zhang L; Wang F; Yi S; Wang J; Fu Y; Zhang Y
Cell Commun Signal; 2022 Jun; 20(1):93. PubMed ID: 35715817
[TBL] [Abstract][Full Text] [Related]
31. Parthanatos and its associated components: Promising therapeutic targets for cancer.
Zhou Y; Liu L; Tao S; Yao Y; Wang Y; Wei Q; Shao A; Deng Y
Pharmacol Res; 2021 Jan; 163():105299. PubMed ID: 33171306
[TBL] [Abstract][Full Text] [Related]
32. Ceramide Induces the Death of Retina Photoreceptors Through Activation of Parthanatos.
Prado Spalm FH; Vera MS; Dibo MJ; Simón MV; Politi LE; Rotstein NP
Mol Neurobiol; 2019 Jul; 56(7):4760-4777. PubMed ID: 30387075
[TBL] [Abstract][Full Text] [Related]
33. Poly(ADP-ribose)polymerase-1 hyperactivation in neurodegenerative diseases: The death knell tolls for neurons.
Narne P; Pandey V; Simhadri PK; Phanithi PB
Semin Cell Dev Biol; 2017 Mar; 63():154-166. PubMed ID: 27867042
[TBL] [Abstract][Full Text] [Related]
34. Poly (ADP-ribose) in the pathogenesis of Parkinson's disease.
Lee Y; Kang HC; Lee BD; Lee YI; Kim YP; Shin JH
BMB Rep; 2014 Aug; 47(8):424-32. PubMed ID: 24874851
[TBL] [Abstract][Full Text] [Related]
35. Programmed Non-Apoptotic Cell Death in Hereditary Retinal Degeneration: Crosstalk between cGMP-Dependent Pathways and PARthanatos?
Yan J; Chen Y; Zhu Y; Paquet-Durand F
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638907
[TBL] [Abstract][Full Text] [Related]
36. Bi-directional regulation of AIMP2 and its splice variant on PARP-1-dependent neuronal cell death; Therapeutic implication for Parkinson's disease.
Lee MH; Um KH; Lee SW; Sun YJ; Gu DH; Jo YO; Kim SH; Seol W; Hwang H; Baek K; Choi JW
Acta Neuropathol Commun; 2024 Jan; 12(1):5. PubMed ID: 38172953
[TBL] [Abstract][Full Text] [Related]
37. Parthanatos participates in glutamate-mediated HT22 cell injury and hippocampal neuronal death in kainic acid-induced status epilepticus rats.
Wang X; Zhang W; Ge P; Yu M; Meng H
CNS Neurosci Ther; 2022 Dec; 28(12):2032-2043. PubMed ID: 35909335
[TBL] [Abstract][Full Text] [Related]
38. Calpain activation is not required for AIF translocation in PARP-1-dependent cell death (parthanatos).
Wang Y; Kim NS; Li X; Greer PA; Koehler RC; Dawson VL; Dawson TM
J Neurochem; 2009 Jul; 110(2):687-96. PubMed ID: 19457082
[TBL] [Abstract][Full Text] [Related]
39. New insights of poly(ADP-ribosylation) in neurodegenerative diseases: A focus on protein phase separation and pathologic aggregation.
Liu C; Fang Y
Biochem Pharmacol; 2019 Sep; 167():58-63. PubMed ID: 31034795
[TBL] [Abstract][Full Text] [Related]
40. Molecular Mechanisms of Parthanatos and Its Role in Diverse Diseases.
Huang P; Chen G; Jin W; Mao K; Wan H; He Y
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
